NULIBRY™ (fosdenopterin)

Approved for Use in the U.S.

Caregivers and healthcare providers, learn more at nulibry.com.

Prescribing Information

 

Personalized support program for patients receiving Nulibry.

Visit ForgingBridges.com to learn more.

TRUSELTIQ™ (infigratinib)

Approved for Use in the U.S.

Patients and healthcare providers, learn more at truseltiq.com.

Prescribing Information

 

Personalized support program for patients receiving Truseltiq.

Visit ForgingBridges.com to learn more.

our products

It is our mission to develop transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Every approved product from BridgeBio represents our commitment to delivering hope through rigorous science.